Gapping up
In reaction to earnings/guidance:
- NKE +11.6%, FDX +5%, RAD +4.5%, CCL +2.8%, TTC +1.8%
Other news:
- ADCT +21.7% (and Sobi announce European Commission approval of ZYNLONTA for the treatment of relapsed or refractory diffuse large b-cell lymphoma)
- SIX +7.6% (shareholder Land & Buildings issues presentation highlighting opportunity to unlock substantial real estate)
- PHG +5.8% (provides update on completed set of test results for first-generation DreamStation sleep therapy devices)
- TTE +2.8% (announces a new gas discovery in offshore block 6)
- LCID +2.1% (begins deliveries of Lucid Air Dream Edition to customers in Europe, confirms official WLTP driving range of up to 883 km)
- ALDX +1.6% (announces new $15 mln share repurchase authorization)
- TCX +1.5% (Blacksheep Fund Management affirms 10.6% holding as active stake; anticipates having further conversations with board members and shareholders)
- PBR +1.4% (begins the non-binding phase for the sale of POSA; concludes the sale of E&P assets in Sergipe)
Analyst comments:
- ADPT +7.8% (upgraded to Overweight from Neutral at Piper Sandler)
- PAGS +2.3% (upgraded to Buy from Neutral at New Street)